Sarepta Therapeutics, Inc. — Director's Dealing 2011

Sep 14, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AVI BIOPHARMA INC (AVII)
CIK: 0000873303
Period of Report: 2011-09-13

Reporting Person: CHASE ANTHONY R (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-09-13	Common Stock	P	20000	$1.2	Acquired	416467	Direct